Biomarkers for cognitive impairment and dementia in elderly people
- 31 August 2008
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 7 (8), 704-714
- https://doi.org/10.1016/s1474-4422(08)70162-5
Abstract
No abstract availableKeywords
This publication has 129 references indexed in Scilit:
- Plasma F2A Isoprostane Levels in Alzheimer’s and Parkinson’s DiseaseNeurodegenerative Diseases, 2007
- CSF Neurofilaments in Frontotemporal Dementia Compared with Early Onset Alzheimer’s Disease and ControlsDementia and Geriatric Cognitive Disorders, 2007
- Cognitive impact of subcortical vascular and Alzheimer's disease pathologyAnnals of Neurology, 2006
- Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s diseaseBiochemical and Biophysical Research Communications, 2006
- Alzheimer's diseaseThe Lancet, 2006
- Frontotemporal dementia: Clinicopathological correlationsAnnals of Neurology, 2006
- Increased levels of CSF phosphorylated tau in apolipoprotein E ɛ4 carriers with mild cognitive impairmentNeuroscience Letters, 2005
- Measurement of Gelatinase B (MMP-9) in the Cerebrospinal Fluid of Patients With Vascular Dementia and Alzheimer DiseaseStroke, 2004
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984